SCHEMBL3972624

SCHEMBL3972624

Cn1cc(C(=O)c2cc(Cl)ncn2)c2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
LMNA P02545 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KMT2A Q03164 2/20 0.50
MITF O75030 1/20 0.50
MAPT P10636 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
NR4A2 P43354 1/20 0.48
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.43
MAOB P27338 2/20 0.42
HTR3E A5X5Y0 1/20 0.41
HTR3B O95264 1/20 0.41
HTR3A P46098 1/20 0.41
HTR3D Q70Z44 1/20 0.41
HTR3C Q8WXA8 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
UTS2R Q9UKP6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3996013 0.86 KDR (0.41) POLBLMNAALDH1A1KMT2AMITF
SCHEMBL3992947 0.86 POLB (0.38) POLBLMNAALDH1A1KMT2AMITF
SCHEMBL3992240 0.86 POLB (0.38) POLBLMNAALDH1A1KMT2AMITF
SCHEMBL3975404 0.85 CREBBP (0.45) POLBALDH1A1KMT2AMAPTHTT
SCHEMBL3990809 0.84 CNR2 (0.60)
SCHEMBL3973488 0.84 NR4A2 (0.51) POLBLMNAALDH1A1KMT2ANR4A2
SCHEMBL3978572 0.84 PCSK9 (0.40) POLBLMNAALDH1A1KMT2AMITF
SCHEMBL3997478 0.84 POLB (0.36) POLBLMNAALDH1A1KMT2AMITF
SCHEMBL3993831 0.84 NTRK1 (0.42) POLBKMT2ANPC1RAB9AMEN1
SCHEMBL3973248 0.84 KDM4E (0.42) POLBALDH1A1NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2065386-A1 CGRP antagonists Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2009-06-03 EP disclosed
EP-2065382-A1 CGRP antagonists Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2009-06-03 EP disclosed
WO-2009050237-A1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed